ES8602041A1 - Procedimiento para la preparacion de derivados succilinados de la heparina n-desulfatada. - Google Patents

Procedimiento para la preparacion de derivados succilinados de la heparina n-desulfatada.

Info

Publication number
ES8602041A1
ES8602041A1 ES537393A ES537393A ES8602041A1 ES 8602041 A1 ES8602041 A1 ES 8602041A1 ES 537393 A ES537393 A ES 537393A ES 537393 A ES537393 A ES 537393A ES 8602041 A1 ES8602041 A1 ES 8602041A1
Authority
ES
Spain
Prior art keywords
modified
antithrombotic activity
glucosaminoglucans
heparin
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537393A
Other languages
English (en)
Spanish (es)
Other versions
ES537393A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of ES537393A0 publication Critical patent/ES537393A0/es
Publication of ES8602041A1 publication Critical patent/ES8602041A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES537393A 1983-10-25 1984-10-24 Procedimiento para la preparacion de derivados succilinados de la heparina n-desulfatada. Expired ES8602041A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23422/83A IT1169888B (it) 1983-10-25 1983-10-25 Glicosaminoglicani modificati dotati di attivita' antitrombotica

Publications (2)

Publication Number Publication Date
ES537393A0 ES537393A0 (es) 1985-11-16
ES8602041A1 true ES8602041A1 (es) 1985-11-16

Family

ID=11206953

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537393A Expired ES8602041A1 (es) 1983-10-25 1984-10-24 Procedimiento para la preparacion de derivados succilinados de la heparina n-desulfatada.

Country Status (7)

Country Link
US (1) US4717719A (https=)
JP (1) JPS60109524A (https=)
CH (1) CH661439A5 (https=)
DE (1) DE3403256A1 (https=)
DK (1) DK508084A (https=)
ES (1) ES8602041A1 (https=)
IT (1) IT1169888B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
US4840940A (en) * 1987-10-21 1989-06-20 Sottiurai Vikrom S Method for reducing the occurrence of distal anastomotic intimal hyperplasia using fractionated heparin
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
AR245455A1 (es) * 1989-08-18 1994-01-31 Ajorca Sa Procedimiento para la obtencion de derivados de heparina,parcial o totalmente n-acetilados en el resto glucosaminico y productos asi obtenidos excluidos sus usos farmaceuticos.
US6140481A (en) * 1994-07-01 2000-10-31 Seikagaku Corporation Process for producing desulfated polysaccharide, and desulfated heparin
GB0216861D0 (en) * 2002-07-19 2002-08-28 Univ Birmingham Saccharide libraries
JP5122436B2 (ja) * 2006-03-14 2013-01-16 国立大学法人 奈良先端科学技術大学院大学 新規なヘパリン代替材料およびその製造方法
US8383156B2 (en) * 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
ES2567079T3 (es) * 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
BR112012026542A2 (pt) 2010-04-16 2016-07-12 Momenta Pharmaceuticals Inc abordagem seletiva de tecido
CA2795868A1 (en) 2010-06-17 2011-12-22 Momenta Pharmaceuticals, Inc. Methods and compositions for modulating hair growth
GB201219696D0 (en) 2012-11-01 2012-12-12 Univ Liverpool Agents for the prevention and/or treatment of central nervous system damamge
JP2016520613A (ja) 2013-05-28 2016-07-14 モメンタ ファーマシューティカルズ インコーポレイテッド 薬学的組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB863235A (en) * 1958-07-05 1961-03-22 Roussel Uclaf Improvements in or relating to organic compounds related to heparin
US3118816A (en) * 1962-04-03 1964-01-21 Abbott Lab N-succinyl heparin and process
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
IT1140999B (it) * 1980-06-18 1986-10-10 Italfarmaco Spa Glicosaminoglicani modificati dotati di attivita' antilipemica e privi di attivita' anticoagulante
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives

Also Published As

Publication number Publication date
DK508084D0 (da) 1984-10-24
US4717719A (en) 1988-01-05
DE3403256A1 (de) 1985-05-02
IT1169888B (it) 1987-06-03
DE3403256C2 (https=) 1990-10-31
JPS6357407B2 (https=) 1988-11-11
IT8323422A0 (it) 1983-10-25
DK508084A (da) 1985-04-26
ES537393A0 (es) 1985-11-16
JPS60109524A (ja) 1985-06-15
CH661439A5 (it) 1987-07-31

Similar Documents

Publication Publication Date Title
ES8602041A1 (es) Procedimiento para la preparacion de derivados succilinados de la heparina n-desulfatada.
FR2538404B1 (https=)
IE810632L (en) Mucopolysaccharides possessing biological properties
DE3167338D1 (en) Stabilisation of factor viii activity in blood plasma
IE881150L (en) Low molecular weight heparins of regular structure, their¹preparation and their biological uses
BG103372A (en) PHARMACEUTICAL COMPOSITION INCLUDING AN ANTI-Xa- ACTIVITY BELONGING COMPOUND AND AN ANTAGONIST COMPOUND OF THROMBOCYTE AGGREGATION
PT86191A (en) Process for the controlled preparation of low molecular glucosaminoglycans
EP0179808A4 (en) MEDICINAL COMPOSITION SUITABLE FOR TREATING OR PROPHYLAXIS OF HEART DISORDERS.
AU7470687A (en) Compositions for preventing graft rejection
HUT44936A (en) Process for producing preparations comprising fibrinolytic and prostacyclin derivative, suitable for treating thrombosis
EP0044343A4 (en) PROTHROMBIN-CONTAINING THERAPEUTIC COMPOSITIONS AND METHOD FOR THE PRODUCTION OF ENZYMATICALLY ACTIVE BLOOD-COUTTERING FACTORS FROM PROTHROMBIN-CONTAINING BLOOD FRACTIONS.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
IL67940A (en) 2,3-di(phenyl or pyridyl)-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
ZA894181B (en) Amblyommin,a new active substance for anticoagulant therapy
IE870577L (en) Topical amide preparation
GR82086B (https=)
EP0340933A3 (en) Heparin-containing formulations
ES8200886A1 (es) Procedimiento para la preparacion de derivados del amino-1 propanol-2
IE832896L (en) Pharmaceutical composition.
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure
AU7491487A (en) Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.
SU1327497A1 (ru) Гидрохлорид 2-аллилтио-4,5-дифенилимидазола, обладающий стресс-протективной активностью и ускоряющий процессы восстановления после физических нагрузок